SCHEMBL19148204

SCHEMBL19148204

FC(F)c1cc(C(F)Cl)c2ccccc2n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 2/20 0.38
▸ MAOB P27338 1/20 0.38
▸ ADORA2A P29274 3/20 0.38
▸ ADORA1 P30542 2/20 0.38
▸ TDP1 Q9NUW8 3/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.36
▸ BACE1 P56817 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.34
▸ GLA P06280 2/20 0.34
▸ CHRM2 P08172 1/20 0.34
▸ ADRA2A P08913 1/20 0.34
▸ ADORA3 P0DMS8 1/20 0.34
▸ CHRM1 P11229 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ NQO2 P16083 1/20 0.34
▸ DRD1 P21728 1/20 0.34
▸ ACHE P22303 1/20 0.34
▸ SLC6A2 P23975 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3291837 0.87 TDP1 (0.43) MAOAMAOBADORA2AADORA1TDP1
SCHEMBL19150095 0.80 BCHE (0.37) ALDH1A1BACE1KDM4EACHEGAA
SCHEMBL29632453 0.79 MAOA (0.45) MAOAMAOBADORA2AADORA1TDP1
SCHEMBL19148213 0.77 ADORA2A (0.64) ADORA2AADORA1BACE1KMT2AMAPK1
SCHEMBL3297357 0.77 MAOA (0.42) MAOAMAOBADORA2AADORA1TDP1
SCHEMBL29029744 0.77 MYC (0.46) MAOAMAOBADORA2AADORA1TDP1
SCHEMBL17673275 0.75 CYP1A2 (0.58) L3MBTL1ALDH1A1BACE1POLBKDM4E
SCHEMBL26632761 0.72 MAOA (0.38) MAOAMAOBADORA2AADORA1TDP1
SCHEMBL26407107 0.71 HTR3A (0.48) L3MBTL1KDM4ECYP1A2KMT2AHTT
SCHEMBL19150086 0.70 POLB (0.43) ALDH1A1POLBCHRM1ACHEKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10266494-B2 Process for the preparation of polyfluoroalkylated quinolines BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-04-23 — — US disclosed
US-20190023659-A1 PROCESS FOR THE PREPARATION OF POLYFLUOROALKYLATED QUINOLINES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-01-24 — — US disclosed
EP-3405458-A1 PROCESS FOR THE PREPARATION OF POLYFLUOROALKYLATED QUINOLINES Bayer CropScience Aktiengesellschaft (DE) 2018-11-28 — — EP disclosed
WO-2017125318-A1 PROCESS FOR THE PREPARATION OF POLYFLUOROALKYLATED QUINOLINES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-07-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190023659-A1 PROCESS FOR THE PREPARATION OF POLYFLUOROALKYLATED QUINOLINES KCNQ1, KCNQ2, KCNQ4 MAOA 311/4885MAOB 303/4885ADORA2A 2373/4885
US-10266494-B2 Process for the preparation of polyfluoroalkylated quinolines KCNQ1, KCNQ2, KCNQ4 MAOA 311/4885MAOB 303/4885ADORA2A 2373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback